Injective holds $6.82 support amid weak momentum and continued downward price move
Injective (INJ) is trading at $7.18, down 7.92% over the last 24 hours. The price is currently below key short- and medium-term moving averages, while holding above longer-term trend indicators.
Highlights
- INJ/USD is trading below key short- and medium-term moving averages, indicating persistent downside momentum.
- Momentum indicators, including MACD and ADX, confirm a broadly bearish bias, with sellers dominating intraday action.
- INJ/USD is expected to fluctuate between $6.82 and $7.41 in the next two to three days, with a higher probability of further downside.
Momentum weakens as sellers dominate below resistance
On the hourly chart, INJ/USD remains below the MA-20 at $7.55 and MA-50 at $7.74, while price action is sustained above the MA-200 at $5.47. The Ichimoku Kijun level at $7.56 serves as immediate resistance. Momentum indicators show broad weakness: both MACD and ADX signal selling conditions, while RSI stands at 38.13 and CCI highlights additional downside risk. Bull/Bear Power also indicates clear seller dominance intraday, although the Stochastic RSI and Awesome Oscillator are neutral, pointing to mixed short-term oscillators.
Volatility persists amid downside risk and resistance test
Over the next two to three trading days, INJ is expected to fluctuate between $6.82 and $7.41, reflecting continued volatility. The probability of further gains is very low, while substantial downside risk persists within this volatility band. A bullish scenario would require a decisive move above the $7.56 resistance, whereas a break below the $6.82 support could open the way for additional losses.
Earlier, analysts noted that Injective was exhibiting persistent short- and medium-term weakness despite positive ecosystem developments. The latest technical signals reinforce this view, suggesting traders should monitor the $7.56 resistance and $6.82 support as key levels for any potential breakouts or downside extension.